Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States.
Gossamer Bio stock last closed at $0.81, down 3.56% from the previous day, and has increased 9.42% in one year. It has overperformed other stocks in the Biotechnology industry by 0.87 percentage points. Gossamer Bio stock is currently +62.93% from its 52-week low of $0.50, and -47.55% from its 52-week high of $1.55.
At the moment, there are 227.22M shares of GOSS outstanding. The market cap of GOSS is $184.73M. In the past 24 hours, 1.6M GOSS shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy GOSS stock.
Based on our research, eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've selected the right brokerage, the next step is to fill out some personal info so you are able to buy GOSS stock today.
Now that you've created your account on the best stock market app for beginners, you need to deposit funds:
Watch the tutorial below to see the process of transferring money into your new investment account.
Once you have selected the best place to buy Gossamer Bio stock, it's very important to research their stock before you buy, so you truly understand the risk and upside.
WallStreetZen was created to help part-time investors perform more in-depth fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on GOSS's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge GOSS's intrinsic value.
Using relative valuations methods:
You can access additional valuation research on GOSS's stock here.
Out of 3 Wall Street analysts who give forecasts on GOSS, the consensus analyst rating on GOSS is a Strong Buy
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Gossamer Bio stock forecast page.
In the last 12 months, insiders at GOSS have bought more shares than they have sold.
Richard Aranda, Chief Medical Officer of GOSS, was the latest GOSS insider to sell. They sold $1,259.28 worth of GOSS shares on Jun 24, 2024.
Research more about who owns GOSS shares here.
No, Gossamer Bio doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
You have two main order types:
Hit the Open Trade button and eToro will execute your order.
If you need additional assistance investing in stocks on eToro, watch the how to video below:
Now that you own some GOSS stock, you'll want to stay up-to-date on your shares.
Put GOSS on a watchlist to get alerted to the latest events about your GOSS stock.
To reiterate, here are the 6 steps to buy stock in Gossamer Bio:
If you require a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you want to keep an eye on your investment in Gossamer Bio, click below.